🚨 New Publication! 🚨
Excited to share our new article in @JCGjournal:
“Comparison of Ustekinumab and Vedolizumab Effectiveness in Perianal Crohn’s Disease”
Our findings suggest a potential effectiveness benefit of UST over VZD in patients with PCD, with lower rates of fistula-related surgery and antibiotic use.
@JHashashMD@FarrayeIBD@OmarMTag@jensemineriomd
👉 Read the article here:
doi.org/10.1097/mcg.00000000…
Feeling very grateful to see our study featured in GI & Hepatology News 🙏
This work would not have been possible without the kindness, mentorship, and support of @Alomari_MD , @AsadurRahman87 , @JHashashMD . Truly thankful to learn from such wonderful mentors along the way 🤍
📣Calling all GI dietitians! Join us and #DIGID for a meetup at #DDW2026! 🥕🍎 Add this date your DDW calendar ⬇️
📅 Monday, May, 4, 1 p.m.
📍 AGA Central (West Central Concourse, Level 3)
ow.ly/x9jN50YK6aT
Insights from our newest CPU on gastric polyps, published in @AGA_CGH, highlight:
☑️ Multiple polyp types can coexist
☑️ Histology matters for diagnosis
☑️ Detection surveillance are key
Read more here: ow.ly/PSfs50YBoAC@SeragHashem; @RobHuangMD
Looks like about half of folks say continue #IFX, half on the #vedo or #IL23i train.
Important Considerations:
- impact of #IBD therapy on #melanoma progression/response
- impact of ongoing smoldering, mild #UC
- impact of #ICI therapy on #IBD
All 🫵 you need to know 🤓about 🩺🩻 evaluation and management 🩼💊💉 of Inpatient #IBD in @AmerGastroAssn@AGA_Gastro
✅Acute severe colitis
✅Small bowel obstruction
✅Intra-abdominal abscess
✅Perinal disease
‼️🚨DVT prophylaxis is critical🚨‼️
gastrojournal.org/article/S0…
Underrated part of conferences #CCCongress26@CrohnsColitisFn@AmerGastroAssn —- chance meetings in unexpected places
@JHashashMD and I ran into @IBD_Afzali in the airport
What did we talk about…..
TSA
being lucky in life
….and a stranger who asked us to watch his bag?!?